Ali Nabavizadeh, MD
Assistant Professor of Radiology at the Hospital of the University of Pennsylvania
Active Radiologist, Penn Presbyterian Medical Center
Active Radiologist , Pennsylvania Hospital
Attending Radiologist, Hospital of the University of Pennsylvania
Radiologist , Chester County Hospital
Department: Radiology
Contact information
Hospital of the University of Pennsylvania
Department of Radiology
3400 Spruce Street
Philadelphia, PA 19104
Department of Radiology
3400 Spruce Street
Philadelphia, PA 19104
Publications
Education:
MD (School of Medicine)
Shiraz Medical School, 2002.
Permanent linkMD (School of Medicine)
Shiraz Medical School, 2002.
Description of Clinical Expertise
Dr. Nabavizadeh is primarily an adult neuroradiologist with additional training in pediatric neuroradiology and nuclear radiology. He specializes in using neuroimaging to diagnose various diseases of the central nervous system.Description of Research Expertise
Dr. Nabavizadeh is currently the principal investigator of multiple imaging clinical trials in patients with brain tumors. His research efforts involve multimodality imaging using structural and physiologic MRI imaging with additional PET probes and molecular imaging techniques to better understand the complex nature of brain tumor microenvironment. The ultimate goal of his research is to use imaging and liquid biopsy biomarkers in prognostication, tumor response evaluation, differentiation of tumor progression from treatment-effect.Selected Publications
Jacob G Eide , Rijul S Kshirsagar , Jacob C Harris , Alyssa Civantos , Robert M Brody , John Y K Lee , Michelle Alonso-Basanta , Jillian W Lazor , Ali Nabavizadeh , Beverly Y Wang , Edward C Kuan , James N Palmer , Nithin D Adappa : Multi-institutional review of sinonasal and skull base chondrosarcoma: A 20-year experience. Head Neck Sep 2022.Amir Nazem, Samantha C. Guiry, Mehrdad Pourfathi, Jeffrey B. Ware, Hannah Anderson, Srikant Kamesh Iyer, Brianna F Moon, Yi Fan, Walter R. Witschey, Rahim Rizi, Stephen J. Bagley, Arati Desai, Donald M. O’Rourke, Steven Brem, MacLean Nasrallah, Ali Nabavizadeh: MR Susceptibility Imaging for Detection of Tumor-Associated Macrophages in Glioblastoma. Journal of Neuro-Oncology 156(3): 645-653, Feb 2022.
Hamed Akbari, Anahita Fathi Kazerooni, Jeffrey B Ware, Elizabeth Mamourian, Hannah Anderson, Samantha Guiry, Chiharu Sako, Catalina Raymond, Jingwen Yao, Steven Brem, Donald M O'Rourke, Arati S Desai, Stephen J Bagley, Benjamin M Ellingson, Christos Davatzikos, Ali Nabavizadeh : Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast-enhanced MR imaging. Sci Rep 11(1):15011., July 2021.
Yang F, He Z, Duan H, Zhang D, Li J, Yang H, Dorsey JF, Zou W,Nabavizadeh SA, Bagley SJ, Abdullah K, Brem S, Zhang L, Xu X, Byrne KT, Vonderheide RH, Gong Y, Fan Y.: Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40. Nature Communications 8(12(1):3424), June 2021.
Beswick DM, Hwang PH, Adappa ND, Le CH, Humphreys DO IM, Getz AE, Suh JD, Aasen DM, Abuzeid WM, Chang EH, Kaizer AM, Kindgom TT, Kohanski MA, Nabavizadeh SA, Nayak JV, Palmer JN, Patel ZM, Ramakrishnan VR, Snyderman CH, St John MA, Wild J, Wang EW.: Surgical approach is associated with complication rate in sinonasal malignancy: A multicenter study. Int Forum Allergy Rhinol June 2021.
Stephen J Bagley, Jacob Till, Aseel Abdalla, Kareena K Sangha, Stephanie S Yee, Jake Freedman, Taylor A Black, Jasmin Hussain, Zev A Binder, Steven Brem, Arati S Desai, Donald M O'Rourke, Qi Long, Seyed Ali Nabavizadeh, Erica L Carpenter : Association of plasma cell-free DNA with survival in patients with IDH wild-type glioblastoma. Neurooncol Adv 3(1), Jan 2021.
Nabavizadeh SA, Ware JB, Guiry S, Nasrallah MP, Mays JJ, Till JE, Hussain J, Abdalla A, Yee SS, Binder ZA, O'Rourke DM, Brem S, Desai AS, Wolf R, Carpenter EL, Bagley SJ.: Imaging and histopathologic correlates of plasma cell-free DNA concentration and circulating tumor DNA in adult patients with newly diagnosed glioblastoma. Neurooncol Adv 2(1), Jan-Dec 2020
Jillian W Lazor, Joel M Stein, James Eric Schmitt, Kathryn A Davis, Seyed Ali Nabavizadeh: Epilepsy Lesion Localization is not Predicted by Developmental Venous Anomaly Location or its FDG-PET Metabolic Activity. J Neuroimaging 30(4): 544-550, July 2020.
Srikant Kamesh Iyer, Brianna Moon, Kosha Ruparel, David Roalf, Jae Song, M, Samantha Guiry, Jeffrey Ware, Kurtz R, Nicholas Josselyn, Sanjeev Chawla, S. Ali Nabavizadeh, Walter R. Witschey: Data-driven quantitative susceptibility mapping using loss adaptive dipole inversion (LADI). Journal of Magnetic Resonance Imaging March 2020.
Henderson F, Brem S,O’Rourke DM,Nasrallah M,Buch VP, Young A,Doot R,Pantel A, Desai A, Bagley S, Nabavizadeh SA : 18F-fluciclovine PET to distinguish treatment related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling. Neuro-Oncology Practice March 2020.